Top Markets
Coin of the day
Hemostemix Inc. Hemostemix Inc.

Hemostemix Inc.

HEM
Classement en actions #32153
Hemostemix Inc., a clinical stage biotechnology company, develops,... Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which is in Phase II clinical trial for the treatment of vascular diseases, such as peripheral arterial disease, angina pectoris, and ischemia, as well as heart failure, ischemic and dilated cardiomyopathy, chronic limb threatening ischemia, vascular dementia, and brain function. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.
Prix de l'action
$0.05504527
Dernière synchronisation: 2026-08-17
Capitalisation boursière
$10.89M
Changement (1 jour)
15.38%
Changement (1 an)
-10.64%
Pays
CA
Échange Hemostemix Inc. (HEM)

Catégorie

Historique des divisions d’actions pour Hemostemix Inc. (HEM)
L’action Hemostemix Inc. (symbole : HEM) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 18, 2026.
Une action HEM achetée avant le Aug 18, 2026 équivaudrait aujourd’hui à 0 actions HEM.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR